Soapbox Alert


Have you suffered from a rare or “orphan” disease?

AIDS Favoritism (a) Unfair for You and Your Disease

On the Soapbox site, the headline above is posted nationally. When one clicks on the headline one is brought to the article below. Once there you can input to President Bush, VP Cheney, your Senators and/or Representatives. Be an advocate for FAIR now. It's easy: Copy the article below, enter your zip code, hit the "Go" button and paste the article into an message to the politicians of your choice.
 

 

 Are you aware that the death rate from AIDS in California’s and Illinois’s patients has plummeted 97 percent (b) and 93 percent (c) yet AIDS still receives 10% (d) of the entire federal research budget? The bias towards AIDS has resulted in gross differences in funding for major killers and rare diseases. For example, our government is spending $3,040 on each AIDS patient in research versus the following amounts: $5 - COPD, $25 - hepatitis C, $32 - hepatitis B, $37  cardiovascular disease, $50 - diabetes, $133 - prostate cancer, $143 - Alzheimer’s, and $148 - Parkinson’s disease. (e) 

When one is made aware that there are sixteen diseases that kill a million more Americans than AIDS every year one can only shout, “That’s not FAIR!”

And what is the funding for “orphan diseases”? An orphan disease is a rare illness which has not been "adopted" by the pharmaceutical industry because it provides little financial incentive for the private sector to make and market new medications to treat or prevent it. For these diseases it is especially important for the government to step in with significantly greater research funding. 

There are six thousand rare diseases such as Beckwith-Wiedemann Syndrome, Muscular Dystrophy, Primary Biliary Cirrhosis, Cerebrotendinous Xanthoma, Multiple Sclerosis, Wegener’s Granulomatosis, Graves’ Disease, Frontotemporal Dementia, hemophilia, Gaucher Disease, Goldenhar Syndrome, Autism, Myasthenia Gravis, and Addison’s Disease. The total governmental orphan-disease research allocation is $1.2 billion, (d) which is only $200,000, on average, for each disease. That is grossly insufficient. 

The disproportionate research allocation of $2.9 billion on one disease, HIV/AIDS, is just the tip of the iceberg. The increase in funding for AIDS since 1999 – just the increase – is greater than the 2007 budget for almost every other disease except cancer and CVD. Although the above statistics involve disease research, one cannot help but notice that at present AIDS funding levels, in two more years one will be able to say, “The total amount spent on all AIDS programs is 1/5th of a Trillion dollars (f).  

In addition, the $29 billion Gates Foundation is spending many billions on AIDS research and Warren Buffet has pledged $31 billion more to Gates for the Gates Foundation’s effort. 

“But AIDS is a pandemic and it deserves more funding!” AIDS activists argue. What do they need: more research dollars? No, they need the exact same thing that has resulted in the 97% and 93% decrease in California’s and Illinois’s AIDS deaths: namely, the effective drugs that have been developed, prevention education, harm reduction policies (clean syringes for IV drug users) and the development of health infrastructures so these policies can be distributed.

I am a proud member of The FAIR Foundation (g) – “FAIR” stands for "Fair Allocations in Research." Along with myself, there are thousands of others in all fifty states from Maine to Hawaii who are coming together through the FAIR Foundation to alert America and our politicians on the need for change in our government’s research funding policies. 

“FAIR” believes a disease’s mortality rate should be given emphasis in determining allocations, and other secondary factors should be utilized to insure diseases that cause great suffering but have low mortality rates, like rare or “orphan” diseases, will also receive increased (h) dollars. Research funds should not be allocated based on Hollywood popularity or political correctness. 

It is now time to redirect funding to diseases that are more deserving and currently receiving billions less than AIDS, including orphan diseases and the sixteen (i) that kill over a million more Americans than AIDS annually. Please endorse The FAIR Foundation’s efforts to put an end to AIDS favoritism and recommend that all citizens join their organization in demanding research funding that is fair and equitable for all.

Send the message above to your Senators and Representatives NOW by copying and pasting the message above and using the “GO” button on this page.

After you do that, JOIN The FAIR Foundation today (FREE) at http://www.fairfoundation.org/join.htm.

Footnotes:

a.       http://www.fairfoundation.org/update.htm

b.       http://fairfoundation.org/quiz/quizanswer.htm (CA 97% decline in newly infected patients; from 1992-2005 through 6/30/06, CA all patients = 88 percent decline; IL decline of 93 percent is in all patients)

c.       http://www.health.state.ny.us/nysdoh/hivaids/aidsny_01/section17.pdf

d.       http://www.fairfoundation.org/nih.htm

e.       http://www.fairfoundation.org/factslinks.htm

f.         http://www.kff.org/hivaids/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=33622

g.       http://www.fairfoundation.org/

h.        http://fairfoundation.org/factors.htm

i.          http://www.fairfoundation.org/thesixteen.htm

Congress.org is a public service of Capitol Advantage and is powered by the award-winning Capwiz grassroots advocacy solution. Capwiz is used by over 1200 leading non-profits, trade associations and media websites including AOL, Yahoo!, and MSN. If you would like to test drive Capwiz for your own organization, complete this form and they'll have a Capwiz site customized just for you in just one business day.


In the NewsFAIR Concept | Take the QUIZ | Coma Life" the Book | Links | Contact FAIR | Privacy Policy | HIV/AIDS Deaths in Each State
Get a T-Shirt: Support FAIR Funding & New Organ-Donor Policies! | Opinion Editorials

Copyright © 2010 The FAIR Foundation. All rights reserved
 Webmaster     
. . .    . . . .    . . . . . . .    . . . . . . . . .  . . .    .    .   .  . .   . .